Your perspective on Evrysdi (risdiplam) may help better inform how the medical industry treats people with SMA. This survey will take 2-3 minutes to complete. Your insights are appreciated.
If you have any questions, please email [email protected].
By clicking "Next," you confirm you agree to our consent policy. To review our consent form, click here.